Bath & Body Works (BBWI) Scheduled to Post Quarterly Earnings on Monday

Bath & Body Works (NYSE:BBWI) will be posting its quarterly earnings results before the market opens on Monday, November 25th. Analysts expect Bath & Body Works to post earnings of $0.46 per share for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings data on Wednesday, August 28th. The company reported $0.37 earnings per share for the quarter, topping analysts’ consensus estimates of $0.35 by $0.02. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. The firm had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.54 billion. On average, analysts expect Bath & Body Works to post $3 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Bath & Body Works Stock Up 0.5 %

NYSE:BBWI opened at $30.71 on Friday. The company has a fifty day moving average of $30.55 and a 200 day moving average of $35.91. Bath & Body Works has a 52 week low of $26.20 and a 52 week high of $52.99. The firm has a market capitalization of $6.73 billion, a P/E ratio of 7.44, a P/E/G ratio of 0.98 and a beta of 1.79.

Bath & Body Works Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 6th. Shareholders of record on Friday, November 22nd will be issued a $0.20 dividend. The ex-dividend date is Friday, November 22nd. This represents a $0.80 annualized dividend and a yield of 2.61%. Bath & Body Works’s dividend payout ratio (DPR) is presently 19.37%.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on BBWI shares. Bank of America reduced their target price on shares of Bath & Body Works from $54.00 to $45.00 and set a “buy” rating on the stock in a research report on Thursday, August 29th. Telsey Advisory Group restated an “outperform” rating and set a $42.00 target price on shares of Bath & Body Works in a research note on Monday, November 18th. Wells Fargo & Company lowered their price objective on shares of Bath & Body Works from $35.00 to $32.00 and set an “equal weight” rating on the stock in a research note on Wednesday, November 6th. JPMorgan Chase & Co. lowered their price objective on shares of Bath & Body Works from $42.00 to $39.00 and set a “neutral” rating on the stock in a research note on Thursday, August 29th. Finally, Barclays cut shares of Bath & Body Works from an “equal weight” rating to an “underweight” rating and decreased their target price for the stock from $31.00 to $28.00 in a research note on Friday, November 8th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have given a buy rating to the company. According to MarketBeat, Bath & Body Works currently has a consensus rating of “Moderate Buy” and a consensus target price of $42.25.

Insider Buying and Selling at Bath & Body Works

In other news, CEO Gina Boswell bought 6,000 shares of the firm’s stock in a transaction that occurred on Wednesday, October 9th. The shares were purchased at an average price of $29.64 per share, with a total value of $177,840.00. Following the purchase, the chief executive officer now owns 242,987 shares in the company, valued at approximately $7,202,134.68. The trade was a 2.53 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 0.27% of the stock is owned by company insiders.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.